446 related articles for article (PubMed ID: 28370432)
1. Antigenic diversity of H5 highly pathogenic avian influenza viruses of clade 2.3.4.4 isolated in Asia.
Ohkawara A; Okamatsu M; Ozawa M; Chu DH; Nguyen LT; Hiono T; Matsuno K; Kida H; Sakoda Y
Microbiol Immunol; 2017 May; 61(5):149-158. PubMed ID: 28370432
[TBL] [Abstract][Full Text] [Related]
2. Genetic and antigenic characterization of H5 and H7 avian influenza viruses isolated from migratory waterfowl in Mongolia from 2017 to 2019.
Ulaankhuu A; Bazarragchaa E; Okamatsu M; Hiono T; Bodisaikhan K; Amartuvshin T; Tserenjav J; Urangoo T; Buyantogtokh K; Matsuno K; Hattori T; Kondoh T; Sato M; Takadate Y; Torii S; Isono M; Okuya K; Saito T; Kasajima N; Kida Y; Maruyama J; Igarashi M; Takada A; Kida H; Batchuluun D; Sakoda Y
Virus Genes; 2020 Aug; 56(4):472-479. PubMed ID: 32430568
[TBL] [Abstract][Full Text] [Related]
3. The genetics of highly pathogenic avian influenza viruses of subtype H5 in Germany, 2006-2020.
King J; Harder T; Conraths FJ; Beer M; Pohlmann A
Transbound Emerg Dis; 2021 May; 68(3):1136-1150. PubMed ID: 32964686
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions in antigenic region B of hemagglutinin play a critical role in the antigenic drift of subclade 2.3.4.4 highly pathogenic H5NX influenza viruses.
Li J; Gu M; Liu K; Gao R; Sun W; Liu D; Jiang K; Zhong L; Wang X; Hu J; Hu S; Liu X; Shi W; Ren H; Peng D; Jiao X; Liu X
Transbound Emerg Dis; 2020 Jan; 67(1):263-275. PubMed ID: 31484213
[TBL] [Abstract][Full Text] [Related]
5. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
[TBL] [Abstract][Full Text] [Related]
6. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
[TBL] [Abstract][Full Text] [Related]
7. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
[TBL] [Abstract][Full Text] [Related]
8. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
[TBL] [Abstract][Full Text] [Related]
9. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Clade 7.2 H5 Avian Influenza Viruses That Continue To Circulate in Chickens in China.
Liu L; Zeng X; Chen P; Deng G; Li Y; Shi J; Gu C; Kong H; Suzuki Y; Jiang Y; Tian G; Chen H
J Virol; 2016 Nov; 90(21):9797-9805. PubMed ID: 27558424
[TBL] [Abstract][Full Text] [Related]
12. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
Yuk SS; Erdene-Ochir TO; Kwon JH; Noh JY; Hong WT; Jeong JH; Jeong S; Gwon GB; Shin JI; Sur JH; Song CS
Vaccine; 2017 Mar; 35(9):1316-1322. PubMed ID: 28169074
[TBL] [Abstract][Full Text] [Related]
15. Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.
Nguyen LT; Nishi T; Shichinohe S; Chu DH; Hiono T; Matsuno K; Okamatsu M; Kida H; Sakoda Y
Virology; 2017 Oct; 510():252-261. PubMed ID: 28756116
[TBL] [Abstract][Full Text] [Related]
16. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
[TBL] [Abstract][Full Text] [Related]
17. Antigenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from poultry in India, 2006-2015.
Bhat S; Nagarajan S; Kumar M; Murugkar HV; Kalaiyarasu S; Venkatesh G; Tosh C
Arch Virol; 2017 Feb; 162(2):487-494. PubMed ID: 27812833
[TBL] [Abstract][Full Text] [Related]
18. Respiratory disease due to mixed viral infections in poultry flocks in Egypt between 2017 and 2018: Upsurge of highly pathogenic avian influenza virus subtype H5N8 since 2018.
Hassan KE; El-Kady MF; El-Sawah AAA; Luttermann C; Parvin R; Shany S; Beer M; Harder T
Transbound Emerg Dis; 2021 Jan; 68(1):21-36. PubMed ID: 31297991
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
Gronsang D; Bui AN; Trinh DQ; Bui VN; Nguyen KV; Can MX; Omatsu T; Mizutani T; Nagai M; Katayama Y; Thampaisarn R; Ogawa H; Imai K
Arch Virol; 2017 Aug; 162(8):2257-2269. PubMed ID: 28405766
[TBL] [Abstract][Full Text] [Related]
20. Antigenic variation of clade 2.1 H5N1 virus is determined by a few amino acid substitutions immediately adjacent to the receptor binding site.
Koel BF; van der Vliet S; Burke DF; Bestebroer TM; Bharoto EE; Yasa IW; Herliana I; Laksono BM; Xu K; Skepner E; Russell CA; Rimmelzwaan GF; Perez DR; Osterhaus AD; Smith DJ; Prajitno TY; Fouchier RA
mBio; 2014 Jun; 5(3):e01070-14. PubMed ID: 24917596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
